Inger Brandt

813 total citations
16 papers, 689 citations indexed

About

Inger Brandt is a scholar working on Oncology, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Inger Brandt has authored 16 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Cellular and Molecular Neuroscience and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Inger Brandt's work include Peptidase Inhibition and Analysis (10 papers), Neuropeptides and Animal Physiology (7 papers) and Diabetes Treatment and Management (3 papers). Inger Brandt is often cited by papers focused on Peptidase Inhibition and Analysis (10 papers), Neuropeptides and Animal Physiology (7 papers) and Diabetes Treatment and Management (3 papers). Inger Brandt collaborates with scholars based in Belgium, Taiwan and Netherlands. Inger Brandt's co-authors include Anne‐Marie Lambeir, Ingrid De Meester, Simon Scharpé, Simon Scharpé, Marie-Berthe Maes, Marc Vanderheyden, Jean‐Marie Ketelslegers, Koen Augustyns, Xin Chen and Jurgen Joossens and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Journal of Neurochemistry.

In The Last Decade

Inger Brandt

16 papers receiving 667 citations

Peers

Inger Brandt

ONCOL

CMN

EDM

CCM

Arthur S. Brecher United States

Osamu Asano Japan

Andrea Kopp Lugli Switzerland

Erdös Eg United States

Russell Desnoyer United States

Christian Rimmbach Germany

Keiko Taniguchi Japan

Paul L. Barclay United Kingdom

Ji Hua China

Monica Andersson Sweden

Arthur S. Brecher United States

Inger Brandt

87 ×0.2

ONCOL

69 ×0.2

CMN

181 ×0.8

74 ×0.3

EDM

112 ×1.1

CCM

Citations per year, relative to Inger Brandt Inger Brandt (= 1×) peers Arthur S. Brecher

Countries citing papers authored by Inger Brandt

Since Specialization

Citations

This map shows the geographic impact of Inger Brandt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inger Brandt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inger Brandt more than expected).

Fields of papers citing papers by Inger Brandt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inger Brandt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inger Brandt. The network helps show where Inger Brandt may publish in the future.

Co-authorship network of co-authors of Inger Brandt

This figure shows the co-authorship network connecting the top 25 collaborators of Inger Brandt. A scholar is included among the top collaborators of Inger Brandt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inger Brandt. Inger Brandt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Cammu, Guy, Inger Brandt, Ann Belmans, et al.. (2019). High-sensitivity cardiac troponin release after conventional and minimally invasive cardiac surgery. Anaesthesia and Intensive Care. 47(3). 255–266. 3 indexed citations

Jonckheere, Stijn, Nikolaas De Neve, Koen De Decker, et al.. (2019). Target-Controlled Infusion of Cefepime in Critically Ill Patients. Antimicrobial Agents and Chemotherapy. 64(1). 10 indexed citations

Peeters, Bart, Inger Brandt, K. Desmet, Cornelis L. Harteveld, & Davy Kieffer. (2016). Hb Melusine and Hb Athens-Georgia: potentially underreported in the Belgian population? Four cases demonstrating the lack of detection using common CE-HPLC methods either for glycated hemoglobin (HbA_1C) analysis or Hb variant screening. Acta Clinica Belgica. 71(6). 458–461. 5 indexed citations

Baerts, Lesley, Yannick Waumans, Inger Brandt, et al.. (2015). Circulating Stromal Cell-Derived Factor 1α Levels in Heart Failure: A Matter of Proper Sampling. PLoS ONE. 10(11). e0141408–e0141408. 16 indexed citations

Schouwers, Sofie, Inger Brandt, Johan Willemse, et al.. (2011). Influence of separator gel in Sarstedt S-Monovette® serum tubes on various therapeutic drugs, hormones, and proteins. Clinica Chimica Acta. 413(1-2). 100–104. 24 indexed citations

Brandt, Inger, Melanie Gérard, Kjell Sergeant, et al.. (2008). Prolyl oligopeptidase stimulates the aggregation of α-synuclein. Peptides. 29(9). 1472–1478. 76 indexed citations

Gérard, Melanie, Zeger Debyser, Linda Desender, et al.. (2008). FK506 binding protein 12 differentially accelerates fibril formation of wild type alpha‐synuclein and its clinical mutants A30P or A53T. Journal of Neurochemistry. 106(1). 121–133. 29 indexed citations

Veken, Pieter Van der, Ingrid De Meester, Véronique Dubois, et al.. (2008). Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 1: Identification of dipeptide derived leads. Bioorganic & Medicinal Chemistry Letters. 18(14). 4154–4158. 25 indexed citations

Maes, Marie-Berthe, Véronique Dubois, Inger Brandt, et al.. (2007). Dipeptidyl peptidase 8/9-like activity in human leukocytes. Journal of Leukocyte Biology. 81(5). 1252–1257. 56 indexed citations

10.

Veken, Pieter Van der, Inger Brandt, Yuan‐Shou Chen, et al.. (2007). Irreversible Inhibition of Dipeptidyl Peptidase 8 by Dipeptide-Derived Diaryl Phosphonates. Journal of Medicinal Chemistry. 50(23). 5568–5570. 44 indexed citations

11.

Brandt, Inger, Anne‐Marie Lambeir, Marie-Berthe Maes, Simon Scharpé, & Ingrid De Meester. (2006). Peptide Substrates of Dipeptidyl Peptidases. Advances in experimental medicine and biology. 575. 3–18. 25 indexed citations

12.

Brandt, Inger, Simon Scharpé, & Anne‐Marie Lambeir. (2006). Suggested functions for prolyl oligopeptidase: A puzzling paradox. Clinica Chimica Acta. 377(1-2). 50–61. 75 indexed citations

13.

Brandt, Inger, Bart Devreese, Jozef Van Beeumen, et al.. (2005). Search for substrates for prolyl oligopeptidase in porcine brain. Peptides. 26(12). 2536–2546. 32 indexed citations

14.

Brandt, Inger, Jurgen Joossens, Xin Chen, et al.. (2005). Inhibition of dipeptidyl-peptidase IV catalyzed peptide truncation by Vildagliptin ((2S)-{[(3-hydroxyadamantan-1-yl)amino]acetyl}-pyrrolidine-2-carbonitrile). Biochemical Pharmacology. 70(1). 134–143. 106 indexed citations

15.

Brandt, Inger, Anne‐Marie Lambeir, Jean‐Marie Ketelslegers, et al.. (2005). Dipeptidyl-Peptidase IV Converts Intact B-Type Natriuretic Peptide into Its des-SerPro Form. Clinical Chemistry. 52(1). 82–87. 159 indexed citations

16.

Firbas, F., H. Godwin, Peter Ingwersen, et al.. (1954). Studies in V egetational History in honour of Knud Jessen. 80. 1–308. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact